The following info from the PDR may help:
Avapro (irbesartan) use was not associated with an increased incidence of dry cough, as is typically associated with ACE inhibitor use. In placebo controlled studies, the incidence of cough in irbesartan treated patients was 2.8% versus 2.7% in patients receiving placebo.
Butâ¦
The following potentially important events occurred in
less than 1% of the 1965 patients and at least 5 patients (0.3%) receiving irbesartan in clinical studies:
It cannot be determined whether these events were causally related to irbesartan.
Respiratory: epistaxis, tracheobronchitis,
congestion, pulmonary congestion, dyspnea, wheezing.
Always a possibility??